After fertilization the embryonic genome is inactive until transcription is initiated during the maternal-zygotic transition [1] [2] [3] . This transition coincides with the formation of pluripotent cells, which in mammals can be used to generate embryonic stem cells. To study the changes in chromatin structure that accompany pluripotency and genome activation, we mapped the genomic locations of histone H3 molecules bearing lysine trimethylation modifications before and after the maternal-zygotic transition in zebrafish. Histone H3 lysine 27 trimethylation (H3K27me3), which is repressive, and H3K4me3, which is activating, were not detected before the transition. After genome activation, more than 80% of genes were marked by H3K4me3, including many inactive developmental regulatory genes that were also marked by H3K27me3. Sequential chromatin immunoprecipitation demonstrated that the same promoter regions had both trimethylation marks. Such bivalent chromatin domains also exist in embryonic stem cells and are thought to poise genes for activation while keeping them repressed [4] [5] [6] [7] [8] . Furthermore, we found many inactive genes that were uniquely marked by H3K4me3. Despite this activating modification, these monovalent genes were neither expressed nor stably bound by RNA polymerase II. Inspection of published data sets revealed similar monovalent domains in embryonic stem cells. Moreover, H3K4me3 marks could form in the absence of both sequence-specific transcriptional activators and stable association of RNA polymerase II, as indicated by the analysis of an inducible transgene. These results indicate that bivalent and monovalent domains might poise embryonic genes for activation and that the chromatin profile associated with pluripotency is established during the maternal-zygotic transition.
After fertilization the embryonic genome is inactive until transcription is initiated during the maternal-zygotic transition [1] [2] [3] . This transition coincides with the formation of pluripotent cells, which in mammals can be used to generate embryonic stem cells. To study the changes in chromatin structure that accompany pluripotency and genome activation, we mapped the genomic locations of histone H3 molecules bearing lysine trimethylation modifications before and after the maternal-zygotic transition in zebrafish. Histone H3 lysine 27 trimethylation (H3K27me3), which is repressive, and H3K4me3, which is activating, were not detected before the transition. After genome activation, more than 80% of genes were marked by H3K4me3, including many inactive developmental regulatory genes that were also marked by H3K27me3. Sequential chromatin immunoprecipitation demonstrated that the same promoter regions had both trimethylation marks. Such bivalent chromatin domains also exist in embryonic stem cells and are thought to poise genes for activation while keeping them repressed [4] [5] [6] [7] [8] . Furthermore, we found many inactive genes that were uniquely marked by H3K4me3. Despite this activating modification, these monovalent genes were neither expressed nor stably bound by RNA polymerase II. Inspection of published data sets revealed similar monovalent domains in embryonic stem cells. Moreover, H3K4me3 marks could form in the absence of both sequence-specific transcriptional activators and stable association of RNA polymerase II, as indicated by the analysis of an inducible transgene. These results indicate that bivalent and monovalent domains might poise embryonic genes for activation and that the chromatin profile associated with pluripotency is established during the maternal-zygotic transition.
After fertilization, animals go through cleavage divisions that transform the one-cell egg into a multicellular embryo. During this phase, the genome is often inactive, and zygotic transcription is only initiated during the maternal-zygotic transition. In zebrafish (Danio rerio), the process of zygotic transcription begins 3 h post fertilization, when a period of rapid synchronous cleavages ends and cell cycles lengthen 9 . At this time, embryonic cells (blastomeres) are pluripotent and largely identical 9 . To study the changes in chromatin structure that accompany pluripotency and zygotic genome activation, we mapped the genomic locations of histone H3 modifications and RNA polymerase II (RNA pol II) during this transition. Previous studies have established that nucleosomes with H3K4me3 (catalysed by trithorax group proteins) and H3K27me3 (catalysed by polycomb group proteins) are associated with activation and repression of transcription, respectively 10 . Nucleosomes with H3K36me3 mark regions of transcriptional elongation 11 . By performing western blot analysis on embryos from early blastula stages to gastrulation, we found that RNA pol II phosphorylation and H3K4me3 appeared during the onset of zygotic transcription and were followed by the emergence of H3K36me3 (Fig. 1a) . To determine the genomic locations of RNA pol II, H3K36me3, H3K4me3 and H3K27me3 before and after the maternal-zygotic transition, we performed chromatin immunoprecipitation (ChIP) and identified co-precipitated DNA fragments by hybridization to custom-designed NimbleGen tiling microarrays 12 covering ,31 megabases of the zebrafish genome (ChIP-chip). Peaks were detected using MA2C 13 , a method that normalizes log 2 fold enrichment by probe sequence and signal distribution between ChIP and control, and assigns each probe a normalized, window-smoothed MA2C score. Enriched domains were then defined and associated with RefSeq genes as described in the Methods and Supplementary Fig. 1 . Consistent with the distribution profiles found in cultured cells 14 , RNA pol II was enriched near transcription start sites (Fig. 1b) , and H3K36me3 was detected in gene bodies, peaking towards the 39 end (Fig. 1c) . H3K4me3 was localized to promoter regions (Fig. 1d) , whereas H3K27me3 covered promoters or entire genes ( Fig. 1e and Supplementary Fig. 2) . Notably, the comparison of ChIP-chip profiles before and after the maternal-zygotic transition (Fig. 1b-e and Supplementary Fig. 3 ) revealed that RNA pol II and the analysed histone modifications were not associated with the genome before zygotic genome activation. Inspection of specific genes and genomic regions confirmed the lack of H3 methylation marks before the maternal-zygotic transition as well as their presence thereafter ( Fig. 1f and Supplementary Figs 4 and 5). These results indicate that RNA pol II and the histone modifications H3K36me3, H3K4me3 and H3K27me3 become associated with genomic loci only during the onset of zygotic genome activation.
We next analysed the histone modification patterns that emerged after the maternal-zygotic transition ( Supplementary Fig. 6 and Supplementary Table 1 ; replicate analysis in Supplementary Fig. 7) . Of 683 RefSeq genes, 82% were occupied by H3K4me3 at their promoter. These included 97% of the 367 genes that were zygotically expressed and 64% of the 316 genes that were inactive (that is, genes not occupied by H3K36me3; see Supplementary Discussion 1 and Supplementary Figs 1 and 6 ). The inactive genes were of particular interest, because studies in embryonic stem (ES) cells found that developmental regulatory genes are often inactive and associated with H3K4me3/H3K27me3 domains [4] [5] [6] [7] [8] . We found that in zebrafish blastomeres, 36% of inactive genes were associated with H3K4me3 and H3K27me3 (Fig. 2a, b and Supplementary Fig. 6 ). Gene Ontology (GO) analysis showed that these inactive genes were enriched for those annotated as 'DNA binding', 'transcription factor activity' and 'multicellular organismal development', with P-values of 3.3 3 10 213 , 8.9 3 10 212 and 4.1 3 10 26 , respectively, similar to that seen for ES cells 4, [6] [7] [8] . Among the H3K4me3/H3K27me3 genes were the Hox clusters ( Supplementary Fig. 4) , cmyb (Fig. 2b) , evx1 and irx3. These results indicate that H3K4me3 and H3K27me3 mark regulatory genes in both mammalian ES cells and zebrafish blastomeres.
The presence of H3K4me3 and H3K27me3 on a subset of genes might indicate the simultaneous association of both chromatin marks with a given promoter in the same cells. Such 'bivalent' domains were found in ES cells and have been postulated to poise genes for activation (H3K4me3) while keeping them repressed (H3K27me3) 4 . Alternatively, H3K4me3 marks might occupy a given promoter in only a subset of cells, whereas H3K27me3 marks might be present in a different subpopulation. Indeed, recent experiments in Xenopus have suggested that H3K4me3 and H3K27me3 do not cooccupy the same promoters 15 . In that study, H3K4me3 marks were found at blastula stages but, in contrast to our results (Fig. 2a, b and Supplementary Figs 4-6), H3K27me3 marks were only detected after the onset of gastrulation. This temporal separation of histone modifications would preclude bivalency in Xenopus blastomeres. That study also identified few, if any, bivalently marked promoters during gastrulation 15 . To determine whether bivalent domains exist in zebrafish blastomeres, we performed sequential ChIP analysis ( Supplementary Fig. 8 and Supplementary Discussion 2). Using this assay, we found that H3K4me3/H3K27me3 genes such as cbfb, runx3 and six3b are truly bivalent (Fig. 2c) . These results establish that bivalent chromatin domains are present in pluripotent embryonic cells in vivo.
In addition to the 36% bivalent genes, 28% of inactive genes were associated with H3K4me3 but not H3K27me3 marks (Figs 2a and  3a, b) . Examples of such monovalent genes (H3K4me3 only) included psat1 (phosphoserine aminotransferase 1), which is ultimately expressed in the central nervous system and the eye, and zgc:110784, which is expressed later in the neural crest (Fig. 3a) . GO term analysis did not reveal any enrichment within this class. The existence of such monovalent inactive genes was surprising because H3K27me3 had been postulated to prevent transcription from H3K4me3-bound promoters 4, 5, 16 . However, closer analysis of available human and mouse ES cell data showed that many non-expressed genes also carried monovalent H3K4me3 marks (Supplementary Discussion 3 and Supplementary Fig. 9 ). In contrast to the large fraction of monovalent H3K4me3 genes, very few genes carried monovalent H3K27me3 marks in zebrafish blastomeres (Supplementary Fig. 6 ) and ES cells 6 . These results reveal remarkably similar chromatin profiles between embryonic blastomeres and ES cells.
Recent studies have indicated that genes can be poised for expression by association of RNA pol II with transcription start sites [17] [18] [19] [20] [21] . By examining RNA pol II occupancy, we found that only 17% of monovalent transcription units had detectable RNA pol II associated with their start sites ( Fig. 3b and Supplementary Fig. 6 ). Comparing the ChIP signals for H3K4me3 and RNA pol II (Fig. 3c) showed that even monovalent genes with high levels of H3K4me3 had undetectable levels of RNA pol II. Similarly, many genes in ES cells are associated with H3K4me3 but not RNA pol II (Supplementary Discussion 4) . Taken together, these results reveal that many genes are initially inactive after genome activation yet marked with H3K4me3.
The presence of monovalent genes (H3K4me3 only) without detectable RNA pol II raised the possibility that sequence-specific transcription factors might direct the methylation of H3K4 before recruitment of RNA pol II 22, 23 . Alternatively, H3K4me3 might mark monovalent genes even before the binding of sequence-specific transcription factors and recruitment of RNA pol II. Because only a subset of transcription factors is present at the maternal-zygotic transition, the latter possibility is more likely. To distinguish between these models, we analysed an inducible transgene that encodes EGFP under the control of the heterologous transcription factor Gal4-VP16. The transgene contained 14 upstream binding sites for Gal4-VP16 joined to a minimal viral promoter (Fig. 4a) . Expression of the transgene was dependent on Gal4-VP16 and was not detected before zygotic genome activation (data not shown). This experimental system allowed us to compare occupancy by RNA pol II and H3K4me3 in the presence or absence of Gal4-VP16. As expected, injection of GAL4-VP16 resulted in the occupancy of the reporter gene by both H3K4me3 and RNA pol II after the maternal-zygotic transition (Figs 4b, c) . In the absence of Gal4-VP16, H3K4me3 still marked the promoter, but neither RNA pol II nor H3K27me3 were detected (Fig. 4b, c and data not shown) . These results suggest that monovalent H3K4me3 marks can be established in the absence of sequence-specific activators and without the stable association of RNA pol II.
The chromatin profiles before and after the maternal-zygotic transition lead to three major conclusions about genome activation and pluripotency. First, genome activation is accompanied by the appearance of specific H3 trimethylation marks, indicating that these histone modifications begin to provide regulatory information only during the maternal-zygotic transition. This finding is pertinent to the suggestion that histone marks associated with developmental regulators in human sperm prepare genes for embryonic activation or repression 24 . Our results suggest that if such modifications exist in zebrafish sperm, they are replaced by other marks, or they are erased or diluted during the rapid cleavage divisions before the maternalzygotic transition. Our data are consistent with a report that identified H3K4me3 marks during the maternal-zygotic transition in Xenopus embryos 15 , but in contrast to that study, we detect H3K27me3 modifications already in blastomeres.
Second, our study provides evidence in embryos for the bivalent domains found in ES cells [4] [5] [6] [7] [8] . This finding reveals a shared chromatin landscape between transiently pluripotent cells in the embryo and permanently pluripotent cells in culture 4, 5 . In contrast to the recent proposal that bivalent domains might not exist in embryos 15 , we observe clear evidence for bivalency. This discrepancy could be due to species-specific modes of gene regulation but might also be caused by experimental differences (Supplementary Discussions 2 and 5). The function of bivalent domains has not been fully established. In the context of ES cells, such marks might poise genes for activation, maintain gene repression and pluripotency and control lineage commitment 25 . In the developing embryo, where pluripotency is short lived, such marks might also ensure the proper timing and quantity of developmental regulators 26 . Third, we find that many genes are monovalently marked by H3K4me3 but inactive. This subset of genes has received little attention in ES cell studies, but our analysis of published data sets suggests that many non-expressed genes in ES cells also carry monovalent H3K4me3 marks. Most of these H3K4me3 domains are not associated with detectable levels of RNA pol II, and our experiments with an inducible transgene suggest that H3K4me3 occupancy can be independent of sequence-specific transcriptional activators or stable association with RNA pol II. These H3K4me3 domains might poise genes for activation by creating a platform for the transcriptional machinery 27 . Consistent with this idea, basal transcription factor TFIID has a higher affinity for H3K4me3 than for unmethylated H3K4 23 , indicating that H3K4me3-poised genes might be activated more efficiently or synchronously 21 . Detailed functional studies are needed to test these models and determine how the chromatin signature of embryonic pluripotency is established and regulates development.
METHODS SUMMARY
ChIP. ChIP was performed as described 28 with minor modifications. For sequential ChIP, two changes were made to the protocol: (1) antibody was crosslinked to tosylactivated magnetic Dynabeads (Invitrogen); and (2) chromatin was eluted from the beads in a milder elution buffer. After removal of the beads, 10 ml of each sample was used for analysis of the first ChIP. The remaining 100 ml was used for sequential ChIP. The eluate was diluted tenfold in immunoprecipitation reconstitution buffer to reconstitute the original immunoprecipitation buffer composition. Samples were then pre-cleared by incubation with empty beads. After removal of the beads, half of each sample was subjected to a second round of immunoprecipitation with the tosylactivated beads crosslinked to the antibody against the 'other' modification (that is, the one that was not used in the first ChIP) and the other half was incubated with empty beads as a negative control. Washing, elution and reversal of the crosslinks were performed as in single ChIP. (See also Supplementary Fig. 8 .) All sequential ChIPs were normalized to their input (that is, the signal of the modification analysed in the first round of ChIP), and fold enrichment was calculated over a negative control. ChIP-chip analysis. For analysis on tiling arrays, ChIP material was amplified as previously described 29 using the Sigma GenomePlex Kit to perform one round of amplification. Sample labelling, hybridization, washing and scanning were performed as described in the NimbleChip Arrays user's guide. Each array was normalized by MA2C 13 . Each probe was assigned a MA2C score to reflect the normalized and window-averaged log 2 ratio of ChIP enrichment over control. See Supplementary Fig. 1 for decision trees used to determine the chromatin and RNA pol II status of genes.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
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METHODS
Zebrafish. Zebrafish were maintained and raised under standard conditions. Wild-type and UAS 14 ::GFP 31 embryos were collected at the 1-cell stage, synchronized and allowed to develop to the desired stage at 28 uC. GAL4-VP16 RNA was injected at the 1-cell stage at 48 pg per embryo. Western blotting. For western blotting, embryos were dechorionated immediately after fertilization, allowed to develop to the desired stage, deyolked either manually or, in the case of H3K36me3 mechanically 32 , and snap frozen in liquid nitrogen. For every antibody, equal numbers of embryos were loaded for each developmental stage (RNA pol II (n 5 2), H3K36me3 (n 5 30), H3K4me3 (n 5 5) and H3 (n 5 1)). Samples were run on 6% (RNA pol II) or 15% (histones) acrylamide gels. Tubulin was analysed on all blots as a loading control. Western blots with antibodies that recognize phosphoserine 5 or 2 on the C-terminal domain of RNA pol II indicated that the bandshift in Fig. 1a is due to phosphorylation of the C-terminal domain (data not shown). ChIP. ChIP was performed essentially as described 28 with some minor modifications. Briefly, for each condition, ,200 embryos were carefully staged, dechorionated and fixed in 1.85% formaldehyde for 15 min at 20 uC. Formaldehyde was quenched by adding glycine to a final concentration of 0.125 M. Embryos were rinsed three times in ice-cold PBS, immediately resuspended in cell lysis buffer (10 mM Tris-HCl pH7.5/10 mM NaCl/0.5% NP40) and lysed for 15 min on ice. Nuclei were collected by centrifugation, resuspended in nuclei lysis buffer (50 mM Tris-HCl pH 7.5/10 mM EDTA/1% SDS) and lysed for 10 min on ice. Samples were diluted three times in IP dilution buffer (16.7 mM Tris-HCl pH 7.5/167 mM NaCl/ 1.2 mM EDTA/0.01% SDS) and sonicated to obtain fragments of ,500 bp. Triton X-100 was added to a final concentration of 0.75% and the lysate was incubated overnight while rotating at 4 uC with 25-50 ml of protein G magnetic Dynabeads (Invitrogen) that had been pre-bound to an excess amount of antibody. Bound complexes were extensively washed with RIPA (50 mM HEPES pH 7.6/1 mM EDTA/0.7% DOC/1% Igepal/0.5 M LiCl) and TBS and then eluted from the beads with elution buffer (50 mM NaHCO 3 /1% SDS). Crosslinks were reversed overnight at 65 uC, RNA degraded by a 30 min RNaseA treatment and DNA purified by the QIAquick PCR purification kit (Qiagen). Sequential ChIP. The first round of ChIP was essentially as described above, except for two changes: (1) tosylactivated magnetic Dynabeads (Invitrogen) were used to which antibody was crosslinked according to the protocol provided by the manufacturer; and (2) chromatin was eluted from the beads in a milder elution buffer (50 mM NaHCO 3 /0.1% SDS). Elution was performed at 20 uC for 15 min in 120 ml elution buffer. After removal of the beads, 10 ml was removed from each sample for subsequent analysis of the first ChIP. The volume was adjusted to 300 ml with standard elution buffer (1% SDS), and this sample was then used in the single ChIP protocol. The remaining 100 ml was used for sequential ChIP. The eluate was diluted tenfold in IP reconstitution buffer (30.9 mM Tris pH 7.5/123 mM NaCl/4.6 mM EDTA/0.37% SDS) and Triton X-100 was added to a final concentration of 0.75% to reconstitute the original IP buffer composition. Samples were then pre-cleared by incubating them with empty beads for 30 min at 4 uC. After removal of the beads, one-half of each sample was subjected to a second round of immunoprecipitation with the tosylactivated beads crosslinked to the antibody against the 'other' modification (that is, the one that was not used in the first ChIP) and the other half was incubated with empty beads as a negative control. Washing, elution and reversal of the crosslinks were performed as in single ChIP. (See also Supplementary Fig. 8 .) All sequential ChIPs were normalized to their input (that is, the signal of the modification analysed in the first round of ChIP). Fold enrichment was calculated over a negative control: hoxa13b-ups served as a negative control for H3K27me3 . H3K4me3 sequential ChIPs, because this hoxa13b upstream region is occupied by H3K27me3 but not H3K4me3; b-actin 1 served as a negative control for H3K4me3 . H3K27me3 sequential ChIPs, because this region is occupied by H3K4me3 but not H3K27me3. See Supplementary Discussion 2 for details. ChIP-chip. For analysis on tiling arrays, ChIP material was amplified as previously described 29 using the Sigma GenomePlex Kit to perform one round of amplification. Sample labelling, hybridization, washing and scanning were performed as described in the NimbleChip Arrays User's Guide. H3K4me3 (Abcam ab8580), H3K27me3 (Upstate 07-449) and H3K36me3 (Abcam ab9050) ChIPs were normalized to H3 (ab1791) and RNA pol II (8WG16/Covance MMS-126R) ChIPs were normalized to input. Tiling array design and hybridization. Sequences for each genomic region were retrieved from the Sanger Institute Zv7 sequence via the UCSC genome browser.
Repetitive sequence elements were removed by RepeatMasker. A total of 385,000 50mer probes were printed using NimbleGen technology (NimbleGen) and were spaced at 30 bp, resulting in 80-bp resolution. Tiled regions include specifically selected genes (that is, maternally provided genes, genes that are transcribed at zygotic genome activation, genes important in development and genes known to be expressed in later stages) as well as two large contiguous genomic regions on chromosomes 3 and 11. A comparison of the data obtained using all genes on the array with the data obtained using only the genes on the two contiguous regions resulted in very similar histone modification profiles showing that the array is a good representation of the genome. All co-precipitated DNA fragments from ChIP experiments were labelled and hybridized to the custom-designed array using the standard NimbleGen protocol as described 12 . Probe intensities were extracted using the standard ChIP analysis settings provided in the Nimblescan software (NimbleGen). ChIP-chip normalization and peak calling. After scanning, each array was normalized by MA2C 13 
